Members |
associationTargetComponent |
Analgesic and Calmative (Pharmacor) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet, 10 tablets (trade product pack) |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet, 10 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet, 20 tablets (trade product pack) |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet, 20 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet, 40 tablets (trade product pack) |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet, 40 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) uncoated tablet |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) uncoated tablet, 10 |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) uncoated tablet, 10, blister pack |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) uncoated tablet, 20 |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) uncoated tablet, 20, blister pack |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) uncoated tablet, 40 |
Unknown Cell Type 2 |
Analgesic and Calmative (Pharmacor) uncoated tablet, 40, blister pack |
Unknown Cell Type 2 |
Analgesic/Calmative (Sandoz) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Analgesic/Calmative (Sandoz) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet, 20 tablets (trade product pack) |
Unknown Cell Type 2 |
Analgesic/Calmative (Sandoz) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet, 20 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Analgesic/Calmative (Sandoz) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet, 40 tablets (trade product pack) |
Unknown Cell Type 2 |
Analgesic/Calmative (Sandoz) (codeine phosphate hemihydrate 10 mg + doxylamine succinate 5.1 mg + paracetamol 500 mg) uncoated tablet, 40 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Analgesic/Calmative (Sandoz) uncoated tablet |
Unknown Cell Type 2 |
Analgesic/Calmative (Sandoz) uncoated tablet, 20 |
Unknown Cell Type 2 |
Analgesic/Calmative (Sandoz) uncoated tablet, 20, blister pack |
Unknown Cell Type 2 |
Analgesic/Calmative (Sandoz) uncoated tablet, 40 |
Unknown Cell Type 2 |
Analgesic/Calmative (Sandoz) uncoated tablet, 40, blister pack |
Unknown Cell Type 2 |
Anamorph (morphine sulfate pentahydrate 30 mg) uncoated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Anamorph (morphine sulfate pentahydrate 30 mg) uncoated tablet, 20 tablets (trade product pack) |
Unknown Cell Type 2 |
Anamorph (morphine sulfate pentahydrate 30 mg) uncoated tablet, 20 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Anamorph 30 mg uncoated tablet |
Unknown Cell Type 2 |
Anamorph 30 mg uncoated tablet, 20 |
Unknown Cell Type 2 |
Anamorph 30 mg uncoated tablet, 20, blister pack |
Unknown Cell Type 2 |
Anandron (nilutamide 150 mg) uncoated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Anandron (nilutamide 150 mg) uncoated tablet, 10 tablets (trade product pack) |
Unknown Cell Type 2 |
Anandron (nilutamide 150 mg) uncoated tablet, 10 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Anandron (nilutamide 150 mg) uncoated tablet, 30 tablets (trade product pack) |
Unknown Cell Type 2 |
Anandron (nilutamide 150 mg) uncoated tablet, 30 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Anandron 150 mg uncoated tablet |
Unknown Cell Type 2 |
Anandron 150 mg uncoated tablet, 10 |
Unknown Cell Type 2 |
Anandron 150 mg uncoated tablet, 10, blister pack |
Unknown Cell Type 2 |
Anandron 150 mg uncoated tablet, 30 |
Unknown Cell Type 2 |
Anandron 150 mg uncoated tablet, 30, blister pack |
Unknown Cell Type 2 |
Anapen Auto-Injector 150 microgram/0.3 mL injection: solution, 0.3 mL syringe |
Anapen Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 150 microgram/0.3 mL injection: solution, 0.3 mL syringe |
Anapen Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 150 microgram/0.3 mL injection: solution, 0.3 mL syringe |
Anapen Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 1 x 0.3 mL pen device (trade product pack) |
Anapen Auto-Injector 300 microgram/0.3 mL injection: solution, 0.3 mL syringe |
Anapen Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 300 microgram/0.3 mL injection: solution, 0.3 mL syringe |
Anapen Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 300 microgram/0.3 mL injection: solution, 0.3 mL syringe |
Anapen Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 500 microgram/0.3 mL injection: solution, 0.3 mL syringe |
Anapen Auto-Injector 500 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 500 microgram/0.3 mL injection: solution, 0.3 mL syringe |
Anapen Auto-Injector 500 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 500 microgram/0.3 mL injection: solution, 0.3 mL syringe |
Anapen Auto-Injector 500 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 150 microgram/0.3 mL injection solution, 1 dose |
Anapen Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 1 x 0.3 mL pen device (trade product pack) |
Anapen Auto-Injector 150 microgram/0.3 mL injection solution, 1 dose, injection device |
Anapen Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 150 microgram/0.3 mL injection solution, dose |
Anapen Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 0.3 mL injection device (trade product unit of use) |
Unknown Cell Type 2 |
Anapen Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 1 x 0.3 mL injection device (containered trade product pack) |
Unknown Cell Type 2 |
Anapen Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 1 x 0.3 mL injection device (trade product pack) |
Unknown Cell Type 2 |
Anapen Auto-Injector 300 microgram/0.3 mL injection solution, 1 dose |
Anapen Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 300 microgram/0.3 mL injection solution, 1 dose, injection device |
Anapen Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 300 microgram/0.3 mL injection solution, dose |
Anapen Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector (epinephrine 300 microgram / 0.3 mL) injection, 0.3 mL injection device (trade product unit of use) |
Unknown Cell Type 2 |
Anapen Auto-Injector (epinephrine 300 microgram / 0.3 mL) injection, 1 x 0.3 mL injection device (containered trade product pack) |
Unknown Cell Type 2 |
Anapen Auto-Injector (epinephrine 300 microgram / 0.3 mL) injection, 1 x 0.3 mL injection device (trade product pack) |
Unknown Cell Type 2 |
Anapen Auto-Injector 500 microgram/0.3 mL injection solution, 1 dose |
Anapen Auto-Injector 500 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 500 microgram/0.3 mL injection solution, 1 dose, injection device |
Anapen Auto-Injector 500 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector 500 microgram/0.3 mL injection solution, dose |
Anapen Auto-Injector 500 microgram/0.3 mL injection, 0.3 mL pen device |
Anapen Auto-Injector (epinephrine 500 microgram / 0.3 mL) injection, 0.3 mL injection device (trade product unit of use) |
Unknown Cell Type 2 |
Anapen Auto-Injector (epinephrine 500 microgram / 0.3 mL) injection, 1 x 0.3 mL injection device (containered trade product pack) |
Unknown Cell Type 2 |
Anapen Auto-Injector (epinephrine 500 microgram / 0.3 mL) injection, 1 x 0.3 mL injection device (trade product pack) |
Unknown Cell Type 2 |
Anapen Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
Anapen Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
Anapen Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
Anapen Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
Anapen Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
Anapen Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
Anapen Auto-Injector 500 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
Anapen Auto-Injector 500 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
Anapen Auto-Injector 500 microgram/0.3 mL injection, 0.3 mL injection device |
Unknown Cell Type 2 |
Anaplasma phagocytophila |
Anaplasma phagocytophilum |
Anaprox (naproxen sodium 550 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Anaprox (naproxen sodium 550 mg) film-coated tablet, 50 tablets (trade product pack) |
Unknown Cell Type 2 |
Anaprox (naproxen sodium 550 mg) film-coated tablet, 50 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Anaprox 550 mg film-coated tablet |
Unknown Cell Type 2 |
Anaprox 550 mg film-coated tablet, 50 |
Unknown Cell Type 2 |
Anaprox 550 mg film-coated tablet, 50, blister pack |
Unknown Cell Type 2 |
Anastomosis of organ NOC |
Construction of anastomosis |
Anastomosis of pancreas |
Anastomosis of pancreatic duct |
Anastomosis of stomach to duodenum |
Anastomosis of stomach |
Anastrodex (anastrozole 1 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Anastrodex (anastrozole 1 mg) film-coated tablet, 30 tablets (trade product pack) |
Unknown Cell Type 2 |
Anastrodex (anastrozole 1 mg) film-coated tablet, 30 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Anastrodex 1 mg film-coated tablet |
Unknown Cell Type 2 |
Anastrodex 1 mg film-coated tablet, 30 |
Unknown Cell Type 2 |
Anastrodex 1 mg film-coated tablet, 30, blister pack |
Unknown Cell Type 2 |
Anastrol (anastrozole 1 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Anastrol (anastrozole 1 mg) film-coated tablet, 30 tablets (trade product pack) |
Unknown Cell Type 2 |
Anastrol (anastrozole 1 mg) film-coated tablet, 30 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |
Anastrol 1 mg film-coated tablet |
Unknown Cell Type 2 |
Anastrol 1 mg film-coated tablet, 30 |
Unknown Cell Type 2 |
Anastrol 1 mg film-coated tablet, 30, blister pack |
Unknown Cell Type 2 |
Anastrozole (AN) (anastrozole 1 mg) film-coated tablet (trade product unit of use) |
Unknown Cell Type 2 |
Anastrozole (AN) (anastrozole 1 mg) film-coated tablet, 30 tablets (trade product pack) |
Unknown Cell Type 2 |
Anastrozole (AN) (anastrozole 1 mg) film-coated tablet, 30 tablets, blister pack (containered trade product pack) |
Unknown Cell Type 2 |